Delivery Order SPE2DB24D2205-SPE2DB25FDWRF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.68 firm fixed-price delivery order is for the supply of ROTARIX vaccine oral syringes, 1.5 mL, to support military healthcare programs. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the ROTARIX vaccine oral syringes (1.5 mL). The firm-fixed-price delivery order, valued at $10,682.65, has a period of performance through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $5,140.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rotarix vaccine oral syringes (1.5 mL) and has an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $13,686.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of ROTARIX vaccine oral syringes, 1.5ML, with a completion date of May 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,029.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringes, 1.5 ml in size. This is a firm-fixed-price delivery order contract with a completion date of December 10, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite...
- The federal contract award is for the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML to the U.S. Defense Logistics Agency (DLA), a defense agency. The $14,766.60 firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025, with a completion date of July 18, 2025. This delivery order contract is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA...
- This federal contract award, valued at $11,171.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX VACCINE ORAL SYRINGE 1.5ML product. This is a firm fixed-price delivery order contract with a completion date of January 28, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $8,798.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML, a critical medical product used in federal healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $5,906.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the ROTARIX vaccine oral syringe 1.5ML. The contract has an ultimate completion date of February 10, 2025 and is a Firm Fixed Price Delivery Order. This award is not associated with any set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,383.30 fixed-price delivery order is for the ROTARIX vaccine oral syringe 1.5ML, a critical medical product to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FDWRFDelivery Order
This federal contract award, valued at $5,906.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringes, 1.5 mL, to support military healthcare programs. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There was no set-aside designation for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 1/8/25 |